---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-066162"
form_type: "8-K"
ticker: "FBIO"
cik: "0001429260"
company_name: "Fortress Biotech, Inc."
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:39:00.212498+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Fortress Biotech shareholders approve director slate, KPMG ratification, and equity plan share increases

## Summary
- Elected all 8 directors; Rosenwald received 7.88M for, 279K against; broker non-votes 6.1M.
- Ratified KPMG as auditor for FY2024 with 13.93M for, 325K against.
- Approved Incentive Plan amendment adding 10M shares and raising annual option/SAR limit to 1M shares.
- Approved ESPP amendment adding 1M shares and raising Offering limit to 5,000 shares.
- Approved LTIP amendment extending term to July 15, 2035 with related changes.

## SEC filing metadata
- accession: 0001104659-24-066162
- form_type: 8-K
- ticker: FBIO
- cik: 0001429260
- company_name: Fortress Biotech, Inc.
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1429260/000110465924066162/0001104659-24-066162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1429260/000110465924066162/tm2415823d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-066162
- JSON: https://secwatch.observer/filing/0001104659-24-066162.json
- Plain text: https://secwatch.observer/filing/0001104659-24-066162.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.